Case Report: A Rare Case of Benign Recurrent Intrahepatic Cholestasis-Type 1 With a Novel Heterozygous Pathogenic Variant of ATP8B1

被引:5
|
作者
Suzuki, Hiroyuki [1 ]
Arinaga-Hino, Teruko [1 ]
Sano, Tomoya [1 ]
Mihara, Yutaro [2 ]
Kusano, Hironori [2 ,3 ]
Mizuochi, Tatsuki [4 ]
Togawa, Takao [5 ]
Ito, Shogo [5 ]
Ide, Tatsuya [1 ]
Kuwahara, Reiichiro [1 ]
Amano, Keisuke [1 ]
Kawaguchi, Toshihiro [1 ]
Yano, Hirohisa [2 ]
Kage, Masayoshi [6 ]
Koga, Hironori [1 ]
Torimura, Takuji [1 ]
机构
[1] Kurume Univ Sch Med, Dept Med, Div Gastroenterol, Kurume, Japan
[2] Kurume Univ, Sch Med, Dept Pathol, Kurume, Japan
[3] Natl Hosp Org Kokura Med Ctr, Dept Diagnost Pathol, Fukuoka, Japan
[4] Kurume Univ, Sch Med, Dept Pediat & Child Hlth, Kurume, Japan
[5] Nagoya City Univ Grad, Sch Med Sci, Dept Pediat & Neonatol, Nagoya, Japan
[6] Junshin Gakuen Univ, Dept Med Engn, Fukuoka, Japan
关键词
benign recurrent intrahepatic cholestasis (BRIC); autosomal recessive; cholestasis; progressive familial intrahepatic cholestasis (PFIC); rifampicin; SALT EXPORT PUMP; RIFAMPICIN;
D O I
10.3389/fmed.2022.891659
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Benign recurrent intrahepatic cholestasis type 1 (BRIC1) is a rare autosomal recessive disorder that is characterized by intermittent episodes of jaundice and intense pruritus and caused by pathogenic variants of adenosine triphosphatase phospholipid transporting 8B1 (ATP8B1). The presence of genetic heterogeneity in the variants of ATP8B1 is suggested. Herein, we describe a unique clinical course in a patient with BRIC1 and a novel heterozygous pathogenic variant of ATP8B1. A 20-year-old Japanese man experienced his first cholestasis attack secondary to elevated transaminase at 17 years of age. Laboratory examinations showed no evidence of liver injury caused by viral, autoimmune, or inborn or acquired metabolic etiologies. Since the patient also had elevated transaminase and hypoalbuminemia, he was treated with ursodeoxycholic acid and prednisolone. However, these treatments did not relieve his symptoms. Histopathological assessment revealed marked cholestasis in the hepatocytes, Kupffer cells, and bile canaliculi, as well as a well-preserved intralobular bile duct arrangement and strongly expressed bile salt export pump at the canalicular membrane. Targeted next-generation sequencing detected a novel heterozygous pathogenic variant of ATP8B1 (c.1429 + 2T > G). Taken together, the patient was highly suspected of having BRIC1. Ultimately, treatment with 450 mg/day of rifampicin rapidly relieved his symptoms and shortened the symptomatic period.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] An expanded role for heterozygous mutations of ABCB4, ABCB11, ATP8B1, ABCC2 and TJP2 in intrahepatic cholestasis of pregnancy
    Peter H. Dixon
    Melissa Sambrotta
    Jennifer Chambers
    Pamela Taylor-Harris
    Argyro Syngelaki
    Kypros Nicolaides
    A. S. Knisely
    Richard J. Thompson
    Catherine Williamson
    Scientific Reports, 7
  • [42] A novel homozygous mutation in the USP53 gene as the cause of benign recurrent intrahepatic cholestasis in children: a case report
    Ates, Burcu Berberoglu
    Ceylan, Ahmet Cevdet
    Hizal, Gulin
    Duran, Fatih
    Dogan, Hayriye Tatli
    Hizli, Samil
    TURKISH JOURNAL OF PEDIATRICS, 2023, 65 (06) : 1012 - 1017
  • [43] An expanded role for heterozygous mutations of ABCB4, ABCB11, ATP8B1, ABCC2 and TJP2 in intrahepatic cholestasis of pregnancy
    Dixon, Peter H.
    Sambrotta, Melissa
    Chambers, Jennifer
    Taylor-Harris, Pamela
    Syngelaki, Argyro
    Nicolaides, Kypros
    Knisely, A. S.
    Thompson, Richard J.
    Williamson, Catherine
    SCIENTIFIC REPORTS, 2017, 7
  • [44] Case Report: Novel Pathogenic Variant Detected in Two Siblings with Type 1 Gaucher Disease
    Dursun, Huseyin
    Metli, Kubra
    Bayram, Fahri
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2023, 23 (14) : 1780 - 1783
  • [45] CHARACTERIZATION OF ATP8B1 GENE MUTATIONS AND A HOT LINKED MUTATION FOUND IN CHINESE CHILDREN WITH PROGRESSIVE INTRAHEPATIC CHOLESTASIS AND LOW GGT
    Liu, L. Y.
    Wang, X. H.
    Wang, J. -S
    JOURNAL OF HEPATOLOGY, 2009, 50 : S163 - S163
  • [46] A novel case report of benign recurrent intrahepatic cholestasis-associated USP53 genetic mutation in a Pakistani girl
    Kamran, Tafiya Erum
    Faisal, Seyreen
    Khalid, Rimsha
    Haider, Zaira
    Inam, Rida
    Siddiqui, Yusra
    Iqbal, Munir
    Khan, Sabeen Abid
    SAGE OPEN MEDICAL CASE REPORTS, 2024, 12
  • [47] A Flippase-Independent Function of ATP8B1, the Protein Affected in Familial Intrahepatic Cholestasis Type 1, Is Required for Apical Protein Expression and Microvillus Formation in Polarized Epithelial Cells
    Verhulst, Patricia M.
    van der Velden, Lieke M.
    Oorschot, Viola
    van Faassen, Ernst E.
    Klumperman, Judith
    Houwen, Roderick H. J.
    Pomorski, Thomas G.
    Holthuis, Joost C. M.
    Klomp, Leo W. J.
    HEPATOLOGY, 2010, 51 (06) : 2049 - 2060
  • [48] NR1H4 analysis in patients with progressive familial intrahepatic cholestasis, drug-induced cholestasis or intrahepatic cholestasis of pregnancy unrelated to ATP8B1, ABCB11 and ABCB4 mutations
    Davit-Spraul, Anne
    Gonzales, Emmanuel
    Jacquemin, Emmanuel
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2012, 36 (06) : 569 - 573
  • [49] Case report: A rare case of pyruvate kinase deficiency and Crigler-Najjar syndrome type II with a novel pathogenic variant of PKLR and UGT1A1 mutation
    Wu, Huan
    Wu, Long
    Zhang, Quan
    Zhang, Bao-fang
    FRONTIERS IN GENETICS, 2023, 14
  • [50] Acute recurrent rhabdomyolysis in a Chinese boy associated with a novel compound heterozygous LPIN1 variant: a case report
    Tong, Ke
    Yu, Geng-Sheng
    BMC NEUROLOGY, 2021, 21 (01)